Doctor Alexander Stiby
University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
Impact of ACLY on type 2 diabetes in UK Biobank: A Mendelian randomisation study
Event: ESC Congress 2021 - The Digital Experience
Topic: Pharmacogenetics
Session: Highlights from the Young on cutting edge therapy for lowering lipids
Impact of history of vascular disease on lipoprotein(a) associations with cardiovascular outcomes: a Mendelian randomisation study in 283,658 UK Biobank participants
Event: ESC Congress 2019
Topic: Epidemiology
Session: How good/bad are we in treating lipids
ESC 365 is supported by
